Table: Pharmarise Holdings - 9-MTH group results

Pharmarise Holdings

12/04/2022 09:30

Apr 12 (Reuters)- 
             Pharmarise Holdings Corp 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Feb 28, 2022        Feb 28, 2021     May 31, 2022 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               38.58               38.46            53.24    
                   (+0.3 pct)          (-0.3 pct)       (+1.7 pct)  
  Operating            1.00              761 mln            1.50    
                   (+31.4 pct)         (-0.5 pct)       (+20.7 pct) 
  Recurring            1.01              612 mln            1.44    
                   (+65.7 pct)         (-18.1 pct)      (+12.1 pct) 
  Net                322 mln             114 mln          438 mln   
                  (+182.5 pct)         (-83.8 pct)      (+2.8 pct)  
  EPS               34.60 yen           12.27 yen        47.19 yen  
  EPS Diluted       26.16 yen           9.98 yen                    
  Ann Div                               14.00 yen        14.00 yen  
  -Q2 div              NIL                 NIL                      
  -Q4 div                               14.00 yen        14.00 yen  
  
  NOTE - Pharmarise Holdings Corp. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2796.T